DRUG · Mapped RxNorm record
Carboplatin
Normalized identity: carboplatinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer
NCT02748889
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Etoposide
Normalized identity: etoposideView linked drug · Find medicine records ·
Find other trials using this name
BIOLOGICAL · Unmapped registry intervention
MPDL3280A
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCarboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Small Cell Lung Cancer ( SCLC )unresolved
Interventions
CarboplatinDRUG · verified · RxNorm: carboplatin
EtoposideDRUG · verified · RxNorm: etoposide
MPDL3280ABIOLOGICAL
Sponsors & collaborators
Giuseppe Giacconelead sponsor
Vanderbilt Universitycollaborator
Memorial Sloan Kettering Cancer Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02748889 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.